US$ 22.07
30mg vial of tirzepatide at ₹ 2000/vial | Tirzepatide Injection in Nagpur Tirzepatide 30mg Research Bundle UK
Description
2 , 3 , 4 , 5 , 6 The results of the SURPASS-2 study showed that individuals who had established T2DM and were treated with tirzepatide at doses ranging from 5 to 15 mg for a duration of 40 weeks experienced a reduction in HbA1c levels ranging from 2.09% to 2.46%

7% and 1%, respectively, with placebo (26)

There is no benefit to hiding frequency modifications from the person responsible for your medical safety

Moving outside this range in either direction accelerates degradation

Prescription-only product
